Kalehua Capital Management Llc
Institutional manager — quarterly 13F holdings, Q ending 2026-03-31
Reported value
$141.3M
Q ending 2026-03-31
Prior quarter
$101.1M
Q ending 2025-12-31
Change
+39.8% QoQ
Positions
25
reported holdings
Largest positions
All 25 reported positions, Q ending 2026-03-31. A manager can hold shares, calls and puts on the same security at once — such positions are listed as separate rows. Type: Shares = common stock, Put/Call = option positions (valued at the underlying), Principal = debt. Tickers link to stock pages where covered.
| Holding | Ticker | Type | Value ▼ | Shares |
|---|---|---|---|---|
| Alpha Architect 1-3 Month Box Etf | BOXX | Shares | $25.4M | 218K |
| X4 Pharmaceuticals Inc | XFOR | Shares | $15.4M | 3.7M |
| Surrozen Inc | SRZN | Shares | $11.2M | 385K |
| Veradermics Inc | MANE | Shares | $9.2M | 146K |
| Relay Therapeutics Inc | RLAY | Shares | $9.0M | 901K |
| Sionna Therapeutics Inc | SION | Shares | $7.9M | 197K |
| Aclaris Therapeutics Inc | ACRS | Shares | $6.9M | 1.8M |
| Inhibikase Therapeutics Inc | IKT | Shares | $6.4M | 3.8M |
| Oruka Therapeutics Inc | ORKA | Shares | $5.8M | 119K |
| Pharvaris Nv | Shares | $5.6M | 199K | |
| Uniqure Nv | Shares | $4.8M | 291K | |
| Septerna Inc | SEPN | Shares | $4.7M | 195K |
| Compass Pathways Plc | CMPS | Shares | $4.5M | 820K |
| Leonabio Inc | LONA | Shares | $4.0M | 394K |
| Damora Therapeutics Inc | DMRA | Shares | $3.6M | 139K |
| Gossamer Bio Inc | GOSS | Shares | $3.4M | 10.2M |
| Moonlake Immunotherapeutics | MLTX | Shares | $3.3M | 176K |
| Tyra Biosciences Inc | TYRA | Shares | $2.9M | 74K |
| Pepgen Inc | PEPG | Shares | $1.8M | 1.0M |
| Instil Bio Inc | TIL | Shares | $1.5M | 183K |
| Tenaya Therapeutics Inc | TNYA | Shares | $1.4M | 2.0M |
| Korro Bio Inc | KRRO | Shares | $1.2M | 109K |
| Kalaris Therapeutics Inc | KLRS | Shares | $782K | 136K |
| Diamedica Therapeutics Inc | DMAC | Shares | $423K | 62K |
| Longeveron Inc | LOOP | Shares | $361K | 348K |
Values as reported in public regulatory filings (USD); holdings are reported quarterly, up to 45 days after quarter end, and may contain reporting errors. Nothing here is investment advice.